SEVERE WX : Wind Chill Advisory View Alerts
CLOSINGS: View Closings

FDA approves new drug for migraine sufferers

The US Food and Drug Administration on Monday...

Posted: Dec 24, 2019 9:45 AM

The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.

The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers.

"Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication," Dr. Billy Dunn, acting director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said in a statement Monday.

In a study published last month, the drug showed greater rates of pain and symptom relief from migraine compared to a placebo, with more than 19% of participants given the drug reporting to be pain-free within two hours and nearly 40% relieved of the most bothersome symptoms linked to migraine, which include light and noise sensitivity. This is compared to roughly 12% and 28%, respectively, from the placebo. Nausea, sleepiness and dry mouth were the most commonly reported side effects.

Some migraines can be treated with over-the-counter medications such as ibuprofen, acetaminophen or aspirin, if taken at the first signs of a migraine occurring. When these aren't effective, the most commonly prescribed treatment is a class of drugs called triptans, which are considered more effective than ubrogepant but have a catch: They work by constricting blood vessels around the brain to stop the pain, so they are not considered safe for use by people at risk of cardiovascular disease and stroke. The newly approved drug, on the other hand, has a different molecular target -- a protein involved in the transmission of pain.

An estimated 40 million Americans and 1 billion people worldwide suffer from migraines. The condition affects one in five women and one in 16 men, according to the American Migraine Foundation.

New York Coronavirus Cases

County data is updated nightly.

Cases: 1309403

Reported Deaths: 41974
CountyCasesDeaths
Queens1634647942
Kings1605728149
Suffolk1327482661
Nassau1187352597
Bronx1092905316
Westchester875701832
New York781983480
Erie536051407
Richmond464421394
Monroe45400804
Rockland32660821
Orange29753661
Onondaga28476541
Dutchess17424330
Oneida17346369
Albany17045266
Niagara12602251
Broome11657269
Saratoga968986
Schenectady9021135
Ulster8017199
Rensselaer7262109
Putnam674875
Chautauqua584470
Chemung5739109
Oswego505974
Ontario485583
Steuben4719131
Cayuga460874
Sullivan395449
St. Lawrence385563
Herkimer383967
Wayne381156
Genesee3803101
Cattaraugus352862
Jefferson338827
Madison324376
Livingston281542
Tompkins277925
Cortland271054
Columbia264573
Allegany241375
Montgomery234277
Clinton231718
Tioga229454
Wyoming228444
Fulton224155
Warren220142
Greene214063
Orleans200371
Chenango185044
Otsego180324
Washington161227
Lewis158224
Seneca127647
Franklin12699
Delaware106727
Essex101721
Schoharie9436
Yates86320
Schuyler74510
Hamilton1611
Unassigned62117
Out of NY0168
Rome
Mostly Cloudy
16° wxIcon
Hi: 15° Lo: 11°
Feels Like: 0°
Binghamton
Mostly Cloudy
17° wxIcon
Hi: 21° Lo: 14°
Feels Like: 4°
Rome
Mostly Cloudy
16° wxIcon
Hi: 18° Lo: 13°
Feels Like: 0°
Rome
Mostly Cloudy
16° wxIcon
Hi: 9° Lo: 3°
Feels Like: 0°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
2021 Golfer's Paradise Card - 21 Courses for only $99.99
Saluting Those Who Are Proud 2 Serve